18F α-methyl tyrosine PET studies in patients with brain tumors

Journal of Nuclear Medicine

Volumn 40, Issue 3, 1999, Pages 399-405

  Inoue, Tomio ^a   Shibasaki, Takashi ^a   Oriuchi, Noboru ^a   Aoyagi, Keiko ^a   Tomiyoshi, Katsumi ^a   Amano, Shigeko ^a   Mikuni, Masahiko ^a   Itsurou, Ida ^a   Aoki, Jun ^a   Endo, Keigo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

methyl tyrosine; Brain tumor; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METIROSINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORINE; METIROSINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG UPTAKE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-METHYLTYROSINE; BRAIN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032588271     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine PET. Radiology. 1993;186:45-53.
2. 11C]leucine: routine synthesis by enzymatic resolution. J Nucl Med. 1983;24:515-521.
3. 11C]aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain. J Cereb Blood Flow Metab. 1990:10:727-739.
4. Mitsuka S, Diksic M, Takada A, Yamamoto YL. Influence of the tumor mass on the valine rate constants and on valine incorporation into proteins in an experimental brain tumor model. Neurochem Int. 1992;20:537-551.
5. 11C]tyrosine. Appl Radiat Isot. 1994;45:821-828.
6. 11C-methyl]-alpha-aminoisobutyric acid (AIB). Nucl Med Biol. 1996;23:263-266.
7. Shinoura N, Nishijima M, Hara T, et al. Brain tumors: detection with C-11 choline PET. Radiology. 1997;202:497-503.
8. 11C] choline. J Nucl Med. 1997;38:842-847.
9. 11C]-tyrosine and PET. J Nucl Med. 1995;36:411-419.
10. 11C]-tyrosine PET for visualization and quantitation of the protein synthesis rate. Radiology. 1995;197:221-226.
11. Brock CS, Meikle SR, Price P. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology? Eur J Nucl Med. 1997;24:691-705.
12. Inoue T, Kim EE, Wong FCL, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors. J Nucl Med. 1996;37:1472-1476.
13. Tyler JL, Diksic M, Villemure JG, et al. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med. 1987;28:1123-1133.
14. 18F-fluorodeoxyglucose PET. AJR. 1994;163: 1459-1465.
15. 18F]fluorotyrosine: a new PET tracer of protein synthesis. J Nucl Med. 1989;30:1367-1372.
16. Kubota K, Ishiwata K, Kubota R. et al. Feasibility of fluorine-18-fluorophenylalanine for tumor imaging compared with carbon-11-L-methionine. J Nucl Med. 1996;37:320-325.
17. 18F-alpha-methyl tyrosine using separation and purification system. Nucl Med Commun. 1997;18:169-175.
18. 124IMT. and first clinical results. J Nucl Med. 1990;31:281-286.
19. 123I]iodo-α-methyl tyrosine: competition with natural L-amino acids. J Nucl Med. 1991;32:1225-1228.
20. 18F)fluoro-α-methyl tyrosine: a potential tumor-detecting agent. J Nucl Med. 1998;39:663-667.
21. Amano S, Inoue T, Tomiyoshi K, et al. In vivo comparison of radiopharmaceuticals in detecting breast cancer. J Nucl Med. 1998;39:1424-1427.
22. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol. 1993;3:255-268.
23. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
24. Meikle SR, Bailey DL, Hooper PK, et al. Simultaneous emission and transmission measurement for attenuation correction in whole-body PET. J Nucl Med. 1995;36:1680-1688.
25. Syder WS, Ford MR, Warner GG, Watson SS. "S," absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No. 11. New York, NY: Society of Nuclear Medicine; 1975.
26. 18F-labelled 2-deoxy-2-fluoro-D-glucose. Int J Appl Radiat Isot. 1983;34:893-896.
27. 18F-fluorodeoxyglucose. Health Phys. 1991;60:657-660.
28. Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Walanuki S. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med. 1991;32:699-706.
29. Kawai K, Fujibayashi Y, Saji H, et al. A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodoalpha-methyl-L-tyrosine. J Nucl Med. 1991;32:819-824.
30. 123I-3-iodo-α-methyl-L-tyrosine and preliminary kinetic analysis. Ann Nucl Med. 1995;9:47-50.
31. 11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med. 1997;38:517-522.
32. 18F]fluorodeoxyglucose and positron emission tomography. Neurology. 1982; 32:1323-1329.
33. Oriuchi N, Tomiyoshi K, Inoue T, et al. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med. 1996;37: 457-462.
34. Weber W, Bartenstein P, Gross MW, et al. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med. 1997;38:802-808.
35. 18F-deoxyglucose. Eur J Nucl Med. 1997;24:428-434.
36. Kuwert T, Probst-Cousin S, Woesler B, et al. Iodine-123-α-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. J Nucl Med. 1997;38:1551-1555.
37. Kuwert T, Woesler B, Morgenroth C, et al. Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine. J Nucl Med. 1998;39:23-27.
38. 123iodo-α-methyl-tyrosine: a new potential melanoma seeking compound. Nuklearmedizin. 1980;(suppl 17):179-182.
39. 123I-α-methyltyrosine for the non-invasive detection of intraocular melanomas. Nuklearmedizin. 1981;(suppl 18):840-844.
40. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]flouro2-deoxy-D-glucose. Radiology. 1996;198:225-231.
41. Jarritt PH, Acton PD. PET imaging using gamma camera systems: a review. Nucl Med Commun. 1996;17:758-766.